Oligomerization of G-protein-coupled transmitter receptors

Nature Reviews Neuroscience

Volumn 2, Issue 4, 2001, Pages 274-286

  Bouvier, Michel ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; CHAPERONE; DOPAMINE 1 RECEPTOR; DOPAMINE 5 RECEPTOR; HETEROTRIMERIC GUANINE NUCLEOTIDE BINDING PROTEIN; NEUROTRANSMITTER RECEPTOR;

CAPPING PHENOMENON; DIMERIZATION; ENERGY TRANSFER; FLUORESCENCE; GENETIC COMPLEMENTATION; LIGHT; METABOLISM; REVIEW; SERODIAGNOSIS; SIGNAL TRANSDUCTION; TRANSPORT AT THE CELLULAR LEVEL;

BIOLOGICAL TRANSPORT; DIMERIZATION; ENERGY TRANSFER; FLUORESCENCE; GENETIC COMPLEMENTATION TEST; HETEROTRIMERIC GTP-BINDING PROTEINS; LIGHT; MOLECULAR CHAPERONES; PRECIPITIN TESTS; RECEPTOR AGGREGATION; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D5; RECEPTORS, GABA-A; RECEPTORS, NEUROTRANSMITTER; SIGNAL TRANSDUCTION;

EID: 0035318509     PISSN: 1471003X     EISSN: 14710048     Source Type: Journal    
DOI: 10.1038/35067575     Document Type: Article

References (103)

1. Suryanarayana, S., Von Zastrow, M. & Kobilka, B. K. Identification of intramolecular interactions in adrenergic receptors. J. Biol. Chem. 267, 21991-21994 (1992).
2. Bockaert, J. & Pin, J. P. Molecular tinkering of G protein- coupled receptors: an evolutionary success. EMBO J. 18, 1723-1729 (1999).
3. Crespo, P, Cachero, T. G., Xu, N. & Gutkind, J. S. Dual effect of β-adrenergic receptors on mitogen-activated protein kinase. J. Biol. Chem. 270, 25259-25265 (1995).
4. Bogoyevitch, M. A. et al. Adrenergic receptor stimulation of the mitogen-activated protein kinase cascade and cardiac hypertrophy. Biochem. J. 314, 115-121 (1996).
5. Yamamoto, J., Nagao, M., Kaziro, Y. & Itoh, H. Activation of p38 mitogen-activated protein kinase by signaling through G protein-coupled receptors. Involvement of Gi and Gq/11 subunits. J. Biol. Chem. 272, 27771-27777 (1997).
6. Williams, N. G., Zhong, H. & Minneman, K. P. Differential coupling of α1-, α2-, and β-adrenergic receptors to mitogen-activated protein kinase pathways and differentiation in transfected PC12 cells. J. Biol. Chem. 273, 24624-24632 (1998).
7. Gerhardt, C. C., Gros, J., Strosberg, A. D. & Issad, T. Stimulation of the extracellular signal-regulated kinase 1/2 pathway by human β-3 adrenergic receptor: new pharmacological profile and mechanism of activation. Mol. Pharmacol. 55, 255-262 (1999).
8. Soeder, K. J. et al. The β-3 adrenergic receptor activates mitogen-activated protein kinase in adipocytes through a Gi-dependent mechanism. J. Biol. Chem. 274, 12017-12022 (1999).
9. van Biesen, T. et al. Receptor-tyrosine-kinase- and Gβγ- mediated MAP kinase activation by a common signalling pathway. Nature 376, 781-784 (1995).
10. s and Gi proteins are critically involved in isoproterenol-induced cardiomyocyte hypertrophy. J. Biol. Chem. 274, 9760-9770 (1999).
11. Luttrell, L. M., Della, R. G., van Biesen, T, Luttrell, D. K. & Lefkowitz, R. J. Gβγ subunits mediate Src-dependent phosphorylation of the epidermal growth factor receptor. A scaffold for G protein-coupled receptor-mediated Ras activation. J. Biol. Chem. 272, 4637-4644 (1997).
12. Luttrell, L. et al. Beta-arrestin-dependent formation of β-2- adrenergic receptor-Src protein kinase complexes. Science 283, 655-661 (1999).
13. Hall, R. A. et al. The β-2 adrenergic receptor interacts with the Na/H-exchanger regulatory factor to control NA/H exchange. Nature 329, 626-630 (1998).
14. Mellado, M. et al. The chemokine monocyte chemotactic protein 1 triggers Janus kinase 2 activation and tyrosine phosphorylation of the CCR2B receptor. J. Immunol. 161, 805-813 (1998).
15. Ali, M. S. et al. Dependence on the motif YIPP for the physical association of Jak2 kinase with the intracellular carboxyl tail of the angiotensin II AT1 receptor. J. Biol. Chem. 272, 23382-23388 (1997).
16. Wreggett, K. A. & Wells, J. W. Cooperativity manifest in the binding properties of purified cardiac muscarinic receptors. J. Biol. Chem. 270, 22488-22499 (1995).
17. Heldin, C. H. Dimerization of cell surface receptors in signal transduction. Cell 80, 213-223 (1995).
18. Limbird, L. E., Meyts, P. D. & Lefkowitz, R. J. Beta- adrenergic receptors: evidence for negative cooperativity. Biochem. Biophys. Res. Commun. 64, 1160-1168 (1975).
19. Potter, L. T. et al. Evidence for paired M2 muscarinic receptors. Mol. Pharmacol. 39, 211-221 (1991).
20. Limbird, L. E. & Lefkowitz, R. J. Negative cooperativity among β-adrenergic receptors in frog erythrocyte membranes. J. Biol. Chem. 251, 5007-5014 (1976).
21. Mattera, R., Pitts, B. J., Entman, M. L. & Birnbaumer, L. Guanine nucleotide regulation of a mammalian myocardial muscarinic receptor system. Evidence for homo- and heterotropic cooperativity in ligand binding analysed by computer-assisted curve fitting. J. Biol. Chem. 260, 7410-7421 (1985).
22. Hirschberg, B. T. & Schimerlik, M. I. A kinetic model for oxotremorine M binding to recombinant porcine m2 muscarinic receptors expressed in Chinese hamster ovary cells. J. Biol. Chem. 269, 26127-26135 (1994).
23. Seeman, P. et al. The cloned dopamine D2 receptor reveals different densities for dopamine receptor antagonist ligands. Implications for human brain positron emission tomography. Eur. J. Pharmacol. 227, 139-146 (1992).
24. Avissar, S., Amitai, G. & Sokolovsky, M. Oligomeric structure of muscarinic receptors is shown by photoaffinity labeling: subunit assembly may explain high- and low-affinity agonist states. Proc. Natl Acad. Sci. USA 80, 156-159.
25. Fraser, C. M. & Venter, J. C. The size of the mammalian lung β-2-adrenergic receptor as determined by target size analysis and immunoaffinity chromatography. Biochem. Biophys. Res. Commun. 109, 21-29 (1982).
26. Venter, J. C., Schaber, J. S., U'Prichard, D. C. & Fraser, C. M. Molecular size of the human platelet a2-adrenergic receptor as determined by radiation inactivation. Biochem. Biophys. Res. Commun. 116, 1070-1075 (1983).
27. Venter, J. C., Horne, P., Eddy, B., Greguski, R. & Fraser, C. M. Alpha 1-adrenergic receptor structure. Mol. Pharmacol. 26, 196-205 (1984).
28. Crine, P., Aubry, M. & Potier, M. Incorporation of radiolabeled amino acids into protein subunits of the rat leydig cell gonadotropin receptor: application to the study of receptor structure and turnover. Ann. NY Acad. Sci. 438, 224-236 (1984).
29. Conn, P. M. & Venter, J. C. Radiation inactivation (target size analysis) of the gonadotropin-releasing hormone receptor: evidence for a high molecular weight complex. Endocrinology 116, 1324-1326 (1985).
30. Bouvier, C. et al. Solubilization and characterization of D2- dopamine receptors in an estrone-induced, prolactin- secreting rat pituitary adenoma. J. Neurochem. 47, 1653-1660 (1986).
31. Frame, L. T., Yeung, S. M., Venter, J. C. & Cooper, D. M. Target size of the adenosine R1 receptor. Biochem. J. 235, 621-624 (1986).
32. Herberg, J. T., Codina, J., Rich, K. A., Rojas, F. J. & Iyengar, R. The hepatic glucagon receptor. Solubilization, characterization, and development of an affinity adsorption assay for the soluble receptor. J. Biol. Chem. 259, 9285-9294 (1984).
33. Peterson, G. L., Rosenbaum, L. C., Broderick, D. J. & Schimerlick, M. I. Physical properties of the purified cardiac muscarinic acetylcholine receptor. Biochemistry 25, 3189-3202 (1986).
34. Maggio, R., Vogel, Z. & Wess, J. Co-expression studies with mutant muscarinic/adrenergic receptors provide evidence for intermolecular 'cross-talk' between G-protein-linked receptors. Proc. Natl Acad. Sci. USA 90, 3103-3107 (1993).
35. Monnot, C. et al. Polar residues in the transmembrane domain of the type 1 angiotensin II receptor are required for binding and coupling. Reconstitution of the binding site by co-expression of two deficient mutants. J. Biol. Chem. 271, 1507-1513 (1996).
36. Bai, M., Trivedi, S., Kifor, O., Quinn, S. J. & Brown, E. M. Intermolecular interactions between dimeric calcium- sensing receptor monomers are important for its normal function. Proc. Natl Acad. Sci. USA 96, 2834-2839 (1999).
37. 2+-sensing receptor. J. Biol. Chem. 271, 19537-19545 (1996).
38. Zhu, X. & Wess, J. Truncated V2 vasopressin receptors as negative regulators of wild-type V2 receptor function. Biochemistry 37, 15773-15784 (1998).
39. Benkirane, M., Jin, D. Y, Chun, R. F., Koup, R. A. & Jeang, K. T. Mechanism of transdominant inhibition of CCR5- mediated HIV-1 infection by ccr5delta32. J. Biol. Chem. 272, 30603-30606 (1997).
40. Rodriguez-Frade, J. M. et al. The chemokine monocyte chemoattractant protein-1 induces functional responses through dimerization of its receptor CCR2. Proc. Natl Acad. Sci. USA 96, 3628-3633 (1999).
41. Overton, M. C. & Blumer, K. J. G Protein coupled receptors function as oligomers in vivo. Curr. Biol. 10, 341-344 (2000).
42. Hebert, T. E. et al. A peptide derived from a P2-adrenergic receptor transmembrane domain inhibits both receptor dimerization and activation. J. Biol. Chem. 271, 16384-16392 (1996).
43. White, J. H. et al. Heterodimerization is required for the formation of a functional GABA(B) receptor. Nature 396, 679-682 (1998).
44. Jones, K. A. et al. GABA(B) receptors function as a heteromeric assembly of the subunits GABA(B)R1 and GABA(B)R2. Nature 396, 674-679 (1998).
45. Kaupmann, K. et al. GABA(B)-receptor subtypes assemble into functional heteromeric complexes. Nature 396, 683-687 (1998).
46. Romano, C., Yang, W. L. & O'Malley, K. L. Metabotropic glutamate receptor 5 is a disulfide-linked dimer. J. Biol. Chem. 271, 28612-28616 (1996).
47. Jordan, B. A. & Devi, L. A. G-protein-coupled receptor heterodimerization modulates receptor function. Nature 399, 697-700 (1999).
48. Bai, M., Trivedi, S. & Brown, E. M. Dimerization of the extracellular calcium-sensing receptor (CaR) on the cell surface of CaR-transfected HEK293 cells. J. Biol. Chem. 273, 23605-23610 (1998).
49. Zeng, F. Y. & Wess, J. Identification and molecular characterization of m3 muscarinic receptor dimers. J. Biol. Chem. 274, 19487-19497 (1999).
50. Furthmayr, H. & Marchesi, V. T. Subunit structure of human erythrocyte glycophorin A. Biochemistry 15, 1137-1144 (1976).
51. Cvejic, S. & Devi, L. A. Dimerization of the S-opioid receptor: implication for a role in receptor internalization. J. Biol. Chem. 272, 26959-26964 (1997).
52. Ciruela, F. et al. Immunological identification of A1 adenosine receptors in brain cortex. J. Neurosci. Res. 42, 818-828 (1995).
53. Ng, G. Y. et al. Dopamine D2 receptor dimers and receptor- blocking peptides. Biochem. Biophys. Res. Commun. 227, 200-204 (1996).
54. Angers, S. et al. Detection of P2-adrenergic receptor dimerization in living cells using bioluminescence resonance energy transfer (BRET). Proc. Natl Acad. Sci. USA 97, 3684-3689 (2000).
55. McVey, M. et al. Monitoring receptor oligomerization using time-resolved fluorescence resonance energy transfer and bioluminescence resonance energy transfer: The human S- opioid receptor displays constitutive oligomerization at the cell surface which is not regulated by receptor occupancy. J. Biol. Chem. (in the press).
56. Kroeger, K. M., Hanyaloglu, A. C., Seeber, R. M., Miles, L. E. C. & Eidne, K. A. Constitutive and agonist-dependent homo-oligomerizationof the thyrotropin-releasing hormone receptor; detection in living cells using bioluminescence resonance energy transfer. J. Biol. Chem. (in the press).
57. Rocheville, M. et al. Subtypes of the somatostatin receptor assemble as functional homo-and heterodimers. J. Biol. Chem. 275, 7862-7869 (2000).
58. Roess, D. A., Horvat, R. D., Munnelly, H. & Barisas, B. G. Luteinizing hormone receptors are self-associated in the plasma membrane. Endocrinology 141, 4518-4523 (2000).
59. Bond, R. A. & Bouvier, M. Receptor-based Drug Design (ed. Leff, P.) 363-377 (Marcel Dekker, New York, 1998).
60. b receptor subunit, gb2, required for functional GABAb receptor activity. J. Biol. Chem. 274, 7607-7610 (1999).
61. Kuner, R. et al. Role of heteromer formation in GABAb receptor function. Science 283, 74-77 (1999).
62. Couve, A. et al. Intracellular retention of recombinant GABAb receptors. J. Biol. Chem. 273, 26361-26367 (1998).
63. Margeta-Mitrovic, M., Jan, Y. N. & Jan, L. Y. A trafficking checkpoint controls GABA(B) receptor heterodimerization. Neuron 27, 97-106 (2000).
64. Morello, J. P et al. Pharmacological chaperones rescue cell- surface expression and function of misfolded V2 vasopressin receptor mutants. J. Clin. Invest. 105, 887-895 (2000).
65. Deng, H. et al. Identification of a major co-receptor for primary isolates of HIV-1. Nature 381, 661-666 (1996).
66. Samson, M. et al. Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 382, 722-725 (1996).
67. Liu, R. et al. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 86, 367-377 (1996).
68. Karpa, K. D., Lin, R., Kabbani, N. & Levenson, R. The dopamine D3 receptor interacts with itself and the truncated D3 splice variant d3nf: D3-D3nf interaction causes mislocalization of D3 receptors. Mol. Pharmacol. 58, 677-683 (2000).
69. Nimchinsky, E. A., Hof, P. R., Janssen, W. G. M., Morrison, J. H. & Schmauss, C. Expression of dopamine D3 receptor dimers and tetramers in brain and in transfected cells. J. Biol. Chem. 272, 29229-29237 (1997).
70. George, S. R. et al. A transmembrane domain-derived peptide inhibits D1 dopamine receptor function without affecting receptor oligomerization. J. Biol. Chem. 273, 30244-30248 (1998).
71. Mijares, A., Lebesgue, D., Wallukat, G. & Hoebeke, J. From agonist to antagonist: Fab fragments of an agonist-like monoclonal anti-P2-adrenoceptor antibody behave as antagonists. Mol. Pharmacol. 58, 373-379 (2000).
72. Conn, P. M., Rogers, D. C., Stewart, J. M., Niedel, J. & Sheffield, T. Conversion of a gonadotropin-releasing hormone antagonist to an agonist. Nature 296, 653-655 (1982).
73. Hazum, E. & Keinan, D. Gonadotropin releasing hormone activation is mediated by dimerization of occupied receptors. Biochem. Biophys. Res. Commun. 133, 449-456 (1985).
74. Gregory, H., Taylor, C. L. & Hopkins, C. R. Luteinizing hormone release from dissociated pituitary cells by dimerization of occupied LHRH receptors. Nature 300, 269-271 (1982).
75. Carrithers, M. D. & Lerner, M. R. Synthesis and characterization of bivalent peptide ligands targeted to G-protein-coupled receptors. Chem. Biol. 3, 537-542 (1996).
76. Vila-Coro, A. J. et al. HIV-1 infection through the CCR5 receptor is blocked by receptor dimerization. Proc. Natl Acad. Sci. USA 97, 3388-3393 (2000).
77. Zukin, R. S., Eghbali, M., Olive, D., Unterwald, E. M. & Tempel, A. Characterization and visualization of rat and guinea pig brain κ-opioid receptors: evidence for κ1 and κ2 opioid receptors. Proc. Natl Acad. Sci. USA 85, 4061-4065 (1988).
78. AbdAlla, S., Lother, H. & Quitterer, U. AT1-receptor heterodimers show enhanced G-protein activation and altered receptor sequestration. Nature 407, 94-98 (2000).
79. Gines, S. et al. Dopamine D1 and adenosine A1 receptors form functionally interacting heteromeric complexes. Proc. Natl Acad. Sci. USA 97, 8606-8611 (2000).
80. George, S. R. et al. Oligomerization of μ- and δ-opioid receptors. Generation of novel functional properties. J. Biol. Chem. 275, 26128-26135 (2000).
81. Rocheville, M. et al. Receptors for dopamine and somatostatin: formation of hetero-oligomers with enhanced functional activity. Science 288, 154-157 (2000).
82. Jordan, B. A., Trapaidze, N., Gomes, I., Nivarthi, R. & Devi, L. A. Oligomerization of opioid receptors with P2-adrenergic receptors: a role in trafficking and mitogen-activated protein kinase activation. Proc. Natl Acad. Sci. USA 98, 343-348 (2001).
83. Jordan, B. A. & Devi, L. A. G-protein-coupled receptor heterodimerization modulates receptor function. Nature 399, 697-700 (1999).
84. Zeng, F. Y. & Wess, J. Identification and molecular characterization of m3 muscarinic receptor dimers. J. Biol. Chem. 274, 19487-19497 (1999).
85. Cornea, A., Janovick, J. A., Maya-Nunez, G. & Conn, P. M. Gonadotropin releasing hormone microaggregation: rate monitored by fluorescence resonance energy transfer. J. Biol. Chem. (in the press).
86. Kunishima, N. et al. Structural basis of glutamate recognition by a dimeric metabotropic glutamate receptor. Nature 407, 971-977 (2000).
87. Tsuji, Y. et al. Cryptic dimer interface and domain organization of the extracellular region of metabotropic glutamate receptor subtype 1. J. Biol. Chem. 275, 28144-28151 (2000).
88. Ray, K. & Hauschild, B. C. Cys-140 is critical for metabotropic glutamate receptor-1 dimerization. J. Biol. Chem. 275, 34245-34251 (2000).
89. Romano, C. et al. Covalent and noncovalent interactions mediate metabotropic glutamate receptor mGlu(5) dimerization. Mol. Pharmacol. 59, 46-53 (2001).
90. Zhang, Z., Sun, S., Quinn, S. J., Brown, E. M. & Bai, M. The extracellular calcium-sensing receptor dimerizes through multiple types of intermolecular interactions. J. Biol. Chem. (2000).
91. Lemmon, M. A. et al. Glycophorin A dimerization is driven by specific interactions between transmembrane alpha-helices. J. Biol. Chem. 267, 7683-7689 (1992).
92. Lemmon, M. A. & Engelman, D. M. Specificity and promiscuity in membrane helix interactions. FEBS Lett. 346, 17-20 (1994).
93. Gouldson, P. R. et al. Dimerization and domain swapping in G-protein-coupled receptors. A computational study. Neuropsychopharmacology 23, S60-S77 (2000).
94. Ng, G. Y. et al. Gamma-aminobutyric acid type B receptors with specific heterodimer composition and postsynaptic actions in hippocampal neurons are targets of anticonvulsant gabapentin action. Mol. Pharmacol. 59, 144-152 (2001).
95. Xu, Y., Piston, D. W. & Johnson, C. H. A bioluminescence resonance energy transfer (BRET) system: application to interacting circadian clock proteins. Proc. Natl Acad. Sci. USA 96, 151-156 (1999).
96. Hovius, R., Vallotton, P., Wohland, T. & Vogel, H. Fluorescence techniques: shedding light on ligand-receptor interactions. Trends Pharmacol. Sci. 21, 266-273 (2000).
97. Njuki, F. et al. A new calcitonin-receptor-like sequence in rat pulmonary blood vessels. Clin. Sci. 85, 385-388 (1993).
98. Fluhmann, B., Muff, R., Hunziker, W., Fischer, J. A. & Born, W. A human orphan calcitonin receptor-like structure. Biochem. Biophys. Res. Commun. 206, 341-347 (1995).
99. McLatchie, L. M. et al. RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor. Nature 393, 333-339 (1998).
100. Christopoulos, G. et al. Multiple amylin receptors arise from receptor activity-modifying protein interaction with the calcitonin receptor gene product. Mol. Pharmacol. 56, 235-242 (1999).
101. Dwyer, N. D., Troemel, E. R., Sengupta, P & Bargmann, C. I. Odorant receptor localization to olfactory cilia is mediated by ODR-4, a novel membrane-associated protein. Cell 93, 455-466 (1998).
102. Liu, F. et al. Direct protein-protein coupling enables crosstalk between dopamine D5 and y-aminobutyric acid A receptors. Nature 403, 274-280 (2000).
103. Bergson, C. et al. Regional, cellular, and subcellular variations in the distribution of D1 and D5 dopamine receptors in primate brain. J. Neurosci. 15, 7821-7836 (1995).